The application of unbiased screening techniques, such as co-immunoprecipitation mass spectrometry using recombinant MFAP4, is crucial for the clear identification of cell surface receptors mediating MFAP4 anti-tumor signaling in TNBC cells. This evidence concerns the gene CD177 and neoplasm.